- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Cystic fibrosis-related diabetes.
Displaying page 1 of 1.
EudraCT Number: 2009-009875-37 | Sponsor Protocol Number: CF200901 | Start Date*: 2009-03-11 | ||||||||||||||||
Sponsor Name:Staf Longziekten | ||||||||||||||||||
Full Title: A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes | ||||||||||||||||||
Medical condition: Cystic fibrosis-related diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001916-69 | Sponsor Protocol Number: CF201101 | Start Date*: 2012-05-22 |
Sponsor Name:HagaZiekenhuis, pulmonary department | ||
Full Title: insulin therapy in non-diabetic adults with cystic fibrosis | ||
Medical condition: cystic fibrosis patients without cystic fibrosis related diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005019-28 | Sponsor Protocol Number: P00996 | Start Date*: 2005-05-09 |
Sponsor Name:Papworth Hospital NHS Foundation Trust | ||
Full Title: Diabetes therapy to improve body mass index pulmoanry function in cystic fibrosis subjects with abnormal blood glucose | ||
Medical condition: Cystic fibrosis related diabetes mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002719-27 | Sponsor Protocol Number: GLU2011FC | Start Date*: 2011-12-30 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PARMA | |||||||||||||
Full Title: GLUCOSE METABOLISM AND INFLAMMATORY PARAMETERS UNDER IGF-I TREATMENT IN CYSTIC FIBROSIS | |||||||||||||
Medical condition: PATIENTS WITH CYSTIC FIBROSIS | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002880-86 | Sponsor Protocol Number: 936 | Start Date*: 2013-01-25 | |||||||||||
Sponsor Name:Liverpool Heart and Chest Hospital NHS Trust | |||||||||||||
Full Title: PRESERVING ΒETA-CELLS: ‘RESTING THE PANCREAS’ IN CYSTIC FIBROSIS | |||||||||||||
Medical condition: Cystic Fibrosis Related Diabetes (CFRD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
